Finally, we demonstrated that induction of AHR by CAP+O3 was specific to the mice with pre-existing allergic airways inflammation, and that local delivery of an arginase inhibitor after exposure, significantly reduced the CAP+O3-induced AHR in both models; thus providing further support for the potential of targeting this pathway therapeutically in asthma. This evidence concerns the gene AHR and asthma.